Key result
~30% of Latin American AF patients lack oral anticoagulation, highlighting persistent care gaps.
Observational (n=2,012)
Yes
The LACROSS registry reveals a significant gap in guideline-directed care in Latin America, with nearly 30% of atrial fibrillation patients not receiving indicated oral anticoagulation.
Persistent OAC underuse in Latin American AF warrants clinician vigilance; leaves open questions on regional barriers for targeted studies.
The LACROSS study followed 2,012 patients with atrial fibrillation in Latin America and found that nearly 30% were not receiving oral anticoagulation. Clinical outcomes included notable rates of death, stroke, hospitalization, and bleeding, with higher risk linked to age, diabetes, and renal disease. These findings highlight persistent gaps in anticoagulation use and the need to improve care in the region.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2026) conducted an observational in Atrial fibrillation (n=2,012). Oral anticoagulation was evaluated on Use of oral anticoagulation. Among 2,012 patients with atrial fibrillation in Latin America, nearly 30% were not receiving oral anticoagulation, highlighting persistent gaps in care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: